SRPT Q2 2017 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M

Gross Profit

$34M98.5% margin

Operating Income

-$63M-180.9% margin

Net Income

-$63M-180.1% margin

EPS (Diluted)

$-1.15

QoQ Revenue Growth

+114.2%

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$88M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$450M

Total Liabilities

$72M

Stockholders' Equity

$378M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$0	—
Gross Profit	$34M	-$44M	+178.6%
Operating Income	-$63M	-$62M	-2.0%
Net Income	-$63M	-$62M	-1.2%